Repair Biotechnologies is a biotechnology company with the mission to develop and bring to the clinic therapies.
Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling human beings to improve their health span through targeting the causes of age-related diseases and ageing itself.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 15, 2018 | Seed | $500K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Grapeseed.Bio | — | Seed |